We are live on
!
Find out more
DAWN
Day One Biopharmaceuticals
DAWN
DAWN
Delisted
DAWN was delisted on the 22nd of April, 2026.
174 hedge funds and large institutions have $561M invested in Day One Biopharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 71 increasing their positions, 55 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
24% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 34
25% less capital invested
Capital invested by funds: $747M → $561M (-$186M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
174
Holding in Top 10
1
Calls
$902K
Puts
$581K
Top Buyers
| 1 | +$21.1M | |
| 2 | +$5.24M | |
| 3 | +$4.56M | |
| 4 |
Renaissance Technologies
New York
|
+$4.49M |
| 5 |
Morgan Stanley
New York
|
+$4.43M |
Top Sellers
| 1 | -$45.6M | |
| 2 | -$26.4M | |
| 3 | -$16.2M | |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
-$9.44M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$9.32M |